Source: Christina Cowan-Mytilinaiou
Source: LMU/Jan Greue
Source: LMU/Jan Greue
ChroMe’s research targets an important nexus between metabolism and chromatin. This holds great promise to develop novel
metabolic disease therapeutics, predict disease risk and take new preventive measures that can correct the genetic and epigenetic
predisposition to obesity and diabetes.The research goals of ChroMe are to understand how chromatin is steered by metabolism to sustain
health or cause disease, and to exploit our new knowledge and expertise to develop new therapies.
WHAT WE DO
TRAINING THROUGH RESEARCH
The ChroMe Network trains 15 PhD students in
cutting-edge research at 12 organizations across Europe.
The ChroMe Network combines research and complementary skills training. Our students are exposed to many sectors through secondments, visits, inter-sectorial mentors and career development modules, providing experience, networking opportunities and potential employment.
ChroMe’s research goals are to understand how chromatin is steered by metabolism to sustain health or cause disease, and to exploit our new knowledge and expertise to develop new therapies. 
ChroMe aims to improve the career prospects of our ESRs in the pharma, nutrition, biotech sectors, academia, clinics, government, policy forums and other sectors that promote, manage or catalyse innovation in metabolic health (e.g. venture capital firms, patient support groups).
This project has received funding from the European Union’s Horizon 2020 Research and Innovation
Programme under the Marie Skłodowska-Curie Grant Agreement No 675610.
